Hims & Hers Health, Inc (HIMS) insider trading
Every open-market stock purchase and sale by Hims & Hers Health, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Oluyemi Okupe (CFO) and 4 others sold $6.1M in the last 90 days.
- Last insider buy: David B Wells (Director), $1.2M, 4 months ago.
Last 12 months: insiders bought $1.2M (1 buy) and sold $31.7M (45 sales). Last close $29.42 on Sep 25, 2026.
Recent HIMS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 22, 2026 | Oluyemi Okupe (CFO) | Sold | $877K |
| Sep 22, 2026 | Oluyemi Okupe (CFO) | Bought (not open market) | — |
| Sep 17, 2026 | Oluyemi Okupe (CFO) | Sold | $355K |
| Sep 16, 2026 | Soleil Boughton (C-suite exec) | Sold | $174K |
| Sep 15, 2026 | Michael Chi (COO) | Sold | $398K |
| Sep 15, 2026 | Mohamed Elshenawy (CTO) | Sold | $226K |
| Sep 2, 2026 | Soleil Boughton (C-suite exec) | Sold | $98K |
| Aug 27, 2026 | Andrew Dudum (CEO) | Sold (not open market) | — |
| Aug 25, 2026 | Andrew Dudum (CEO) | Sold (not open market) | — |
| Aug 19, 2026 | Soleil Boughton (C-suite exec) | Sold | $692K |
| Aug 19, 2026 | Oluyemi Okupe (CFO) | Sold | $148K |
| Aug 19, 2026 | Oluyemi Okupe (CFO) | Bought (not open market) | — |
| Aug 18, 2026 | Deborah M. Autor (C-suite exec) | Sold | $467K |
| Aug 17, 2026 | Oluyemi Okupe (CFO) | Sold | $262K |
| Aug 17, 2026 | Oluyemi Okupe (CFO) | Bought (not open market) | — |
| Aug 14, 2026 | Mohamed Elshenawy (CTO) | Sold (not open market) | $2.7M |
| Aug 14, 2026 | Andrew Dudum (CEO) | Sold (not open market) | $2.2M |
| Aug 14, 2026 | Michael Chi (COO) | Sold (not open market) | $1.3M |
| Aug 14, 2026 | Oluyemi Okupe (CFO) | Sold (not open market) | $1M |
| Aug 14, 2026 | Soleil Boughton (C-suite exec) | Sold (not open market) | $605K |
| Aug 14, 2026 | Deborah M. Autor (C-suite exec) | Sold (not open market) | $455K |
| Aug 14, 2026 | Patrick Harrison Carroll (C-suite exec) | Sold (not open market) | $287K |
| Aug 14, 2026 | Irene Becklund (Officer) | Sold (not open market) | $183K |
| Aug 14, 2026 | Soleil Boughton (C-suite exec) | Bought (not open market) | — |
| Aug 14, 2026 | Mohamed Elshenawy (CTO) | Bought (not open market) | — |
Who's trading HIMS
- Oluyemi Okupe, CFO: sold $11M (21 sales), last Sep 22, 2026
- Soleil Boughton, C-suite exec: sold $1.9M (10 sales), last Sep 16, 2026
- Michael Chi, C-suite exec: sold $3.8M (5 sales), last Sep 15, 2026
- Mohamed Elshenawy, CTO: sold $1.2M (2 sales), last Sep 15, 2026
- Andrew Dudum, CEO: sold $11M (9 sales), last Aug 27, 2026
- Deborah M. Autor, C-suite exec: sold $726K (2 sales), last Aug 18, 2026
- David B Wells, Director: bought $1.2M (1 buy), last Aug 14, 2026
- Irene Becklund, Officer: sold $816K (4 sales), last Aug 14, 2026
- Patrick Harrison Carroll, C-suite exec: sold $1.2M (2 sales), last Aug 14, 2026
- Christopher D Payne, Director: other filings, last Aug 14, 2026
- Kare Schultz, Director: other filings, last Aug 14, 2026
- Kofi Owusu Amoo-Gottfried, Director: other filings, last Aug 12, 2026
- Delos M. Cosgrove, Director: other filings, last Aug 12, 2026
- Anja Manuel, Director: other filings, last Aug 12, 2026
- Garcia Andrea G Perez, Director: sold $97.9K (1 sale), last Aug 12, 2026
Get free alerts when an insider at Hims & Hers Health, Inc files a new trade →